I'll try. Thank you very much for your question.
Let me start by saying that tuberculosis is underfunded. We are not following the high-level summit on tuberculosis that was held in New York three years ago. It's underfunded. Across the three diseases, it's the one that kills the most people—1.6 million a year.
Multidrug-resistant TB is a high risk for global health security. MDR-related deaths already represent a third of the deaths in the world related to antimicrobial resistance. That is very, very critical. There is indeed a lot of effort being put into the search for new drugs for MDR-TB. Indeed, this absolutely is one of our key areas of work.